| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.003 |